Clinical Trials Logo

Cardiovascular Diseases clinical trials

View clinical trials related to Cardiovascular Diseases.

Filter by:

NCT ID: NCT03329053 Withdrawn - Clinical trials for Cardiovascular Diseases

Utilization of Physical Activity Recommendations Among Patients of Cardiovascular Healthcare Centres in Eastern Slovakia

AWATAR
Start date: February 23, 2018
Phase: N/A
Study type: Interventional

The aims of this trial are: (A) to determine and compare the indices of exercise recommendations compliance after exercise prescription according to digital training and decision support system as compared to exercise prescription following the standard informative procedure among patients with cardiovascular disease. (B) to determine whether health literacy moderates effect of exercise prescription according to digital training and decision support system on the indices of exercise recommendations compliance among patients with cardiovascular disease.

NCT ID: NCT03318484 Withdrawn - Clinical trials for Cardiovascular Diseases

Sonodynamic Therapy on Patients With Femoropopliteal PAD and Claudication

Start date: November 2017
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this trial is to evaluate the safety and efficacy of sonodynamic therapy (SDT) in reducing atherosclerotic plaques inflammation and increasing peak walking time (PWT) among peripheral artery disease (PAD) patients with symptom of intermittent claudication.

NCT ID: NCT03190798 Withdrawn - Clinical trials for Cardiovascular Diseases

Effects of Canagliflozin on Intravascular Volume and Hemodynamics

Start date: September 1, 2017
Phase: Phase 4
Study type: Interventional

RESEARCH HYPOTHESIS - In subjects with T2DM and HF, effect of canagliflozin will be superior to placebo for the change from baseline in PCWP after a single dose (6 hours post-dose) and after 4 weeks. - Treatment with canagliflozin will be well tolerated over 4 weeks.

NCT ID: NCT03042117 Withdrawn - Clinical trials for Cardiovascular Diseases

Connecting Periodontal and Coronary Artery Disease Via the Inflammatory State of the Body

Start date: October 18, 2016
Phase:
Study type: Observational

Cardiovascular disease is one of the leading causes of death in the United States and the world. Many interventions relating to prevention have been emphasized as more risk factors for this devastating disease are discovered. Periodontal disease is known to have a close association with cardiovascular disease, but its role as a risk factor is still not well understood. Inflammation is a driving force in both of these diseases, creating a potential bridge between the two. Specifically, periodontal disease can cause an inflammatory reaction in the body, which may predispose or even directly contribute to atheroma formation in the coronary arteries. In this study, the investigators will study the link between the inflammatory state of the body and will search for a correlation with levels of coronary artery disease and periodontal disease. Inflammatory markers such as high-sensitivity C-reactive protein (hs-CRP), erythrocyte sedimentation rate (ESR), and immunoglobulin G (IgG) levels in the patient's blood will be analyzed and correlated to clinical attachment loss measured via pocket depth measurement, the distance from the gingival margin to the base of the pocket. A definitive link between these disease processes will allow preventive measures to be taken earlier to prevent this lifelong disease.

NCT ID: NCT03010995 Withdrawn - Nicotine Clinical Trials

The Acute Cardiovascular Effects of Nicotine in E-cigarettes (ACE) Study

ACE
Start date: March 13, 2018
Phase: Phase 1
Study type: Interventional

The goal of this project is to evaluate the nicotine induced acute cardiovascular changes in E-Cigarette users and also study the mechanism involved particularly with vascular impairment.

NCT ID: NCT02871310 Withdrawn - Clinical trials for Cardiovascular Disease

Vasoactive Effects of IQP-AS-118 in Healthy Individuals

Start date: March 2018
Phase: N/A
Study type: Interventional

The main objective of this study is to evaluate the benefit of IQP-AS-118 on the vasoactive effects in healthy subjects.

NCT ID: NCT02866448 Withdrawn - Clinical trials for Cardiovascular Disease

Impact of isoQUercetin and Aspirin on Platelet Function

QUAP
Start date: August 2016
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate the effect of acute isoquercetin supplementation, aspirin, and isoquercetin/aspirin combination on platelet aggregation, blood pressure and vasculat stiffness (eg digital volume pulse), as well as investigating the plasma accumulation and urine excretion profiles of quercetin.

NCT ID: NCT02838355 Withdrawn - Clinical trials for Cardiovascular Disease

Employing End Tidal Capnography in Continuous Flow Ventricular Assist Device Patients

Start date: October 2016
Phase: N/A
Study type: Interventional

The purpose of this study is to explore how the End Tidal Carbon Dioxide monitoring via nasal cannula (ETCO2-NC) device may allow for earlier detection of respiratory complications. This device will detect the amount of carbon dioxide exhaled with each breath and may better predict high levels of this than traditional monitoring. This may reduce the number and severity of respiratory issues. A convenience sample of 60 participants either scheduled for continuous flow left ventricular assist device (CF-LVAD) implant or who have been readmitted to an ICU with a CF-LVAD will be recruited and randomized to usual care or usual care plus ETCO2-NC throughout their stay in the ICU.

NCT ID: NCT02829749 Withdrawn - Clinical trials for Cardiovascular Diseases

Effectiveness and Safety of Mitral Valve Repair With the NeoChord DS1000 Artificial Chordae Delivery System Versus Conventional Surgery in Patients With Severe Primary Mitral Regurgitation Due to Isolated Leaflet Prolapse

MITRACHORD
Start date: June 2020
Phase: N/A
Study type: Interventional

The main objective is to assess the effectiveness and safety of the NeoChord DS1000 repair technique as compared with conventional open-heart on-pump mitral valve surgery in patients with severe primary mitral regurgitation.

NCT ID: NCT02517671 Withdrawn - Clinical trials for Cardiovascular Disease

Impact of Enhanced External Counterpulsation (EECP) on VO2 MAX

Start date: January 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the effects of 35 EECP sessions on cardiopulmonary training performance in healthy volunteers. Data from this study will be used to generate sample size and power calculations for feasibility of future EECP studies. The results of this study could provide evidence that can help active duty and Department of Defense beneficiaries optimize physical conditioning, endurance and overall health.